Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and expression on hepatitis B progression

Journal of Interferon and Cytokine Research

Volumn 34, Issue 2, 2014, Pages 117-128

  Saxena, Roli ^a   Chawla, Yogesh Kumar ^a   Verma, Indu ^a   Kaur, Jyotdeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INDIA; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; LIVER NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84893898754     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0043     Document Type: Article

References (47)

1. Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. 2005. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol 11(21):3260-3263. (Pubitemid 40973896)
2. Alvarado-Navarro A, Montoya-Buelna M, Munoz-Valle JF, Lopez-Roa RI, Guillen-Vargas C, Fafutis-Morris M. 2008. The 3¢UTR 1188A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol Lett 118(2):148-151.
3. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. 1987. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84(17):6020-6024. (Pubitemid 17140174)
4. Ayada M, Ishikawa T, Okumura A, Tanabe J, Ito H, Ohashi T, Matsumoto E, Sato K, Hotta N, Fukuzawa Y, Kakumu S. 2006. Alteration of serum cytokine balances among different phases of chronic hepatitis B virus infection. Hepatol Res 34(4):214-221.
5. Bai J, Lin M, Zeng X, Zhang Y, Wang Z, Shen J, Jiang L, Gao F, Chen Q. 2008. Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: a study in an ethnic Chinese cohort. J Interferon Cytokine Res 28(6):351-358. (Pubitemid 351929934)
6. Berkovic MC, Jokic M, Marout J, Radosevic S, Zjacic-Rotkvic V, Kapitanovic S. 2010. IL-2-330 T/G SNP and serum valuespotential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). J Mol Med (Berl) 88(4):423-429.
7. Boyum A. 1984. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol 108:88-102. (Pubitemid 15215616)
8. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, Chiou HL. 2007. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res 150(2):116-121. (Pubitemid 47081450)
9. Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z. 2009. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin Cancer Res 15(1):400-405.
10. Daly AK, Steen VM, Fairbrother KS, Idle JR. 1996. CYP2D6 multiallelism. Methods Enzymol 272:199-210. (Pubitemid 26299883)
11. Donn RP, Barrett JH, Farhan A, Stopford A, Pepper L, Shelley E, Davies N, Ollier WE, Thomson W. 2001. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British Paediatric Rheumatology Study Group. Arthritis Rheum 44(4):802-810. (Pubitemid 32319772)
12. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, Conti P, Vecchiet J. 2006. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 36(2):144-150.
13. Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R, Pirisi M. 2008. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine 44(2):256-261.
14. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, Wang SY, Tong LX. 2009. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 15(44):5610-5619.
15. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. 1999. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8(1):93-97. (Pubitemid 29039053)
16. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran TP, Jr., Ollier WE, Panayi GS, Lanchbury JS. 2000. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 1(3):219-224.
17. Han SS, Cho EY, Lee TS, Kim JW, Park NH, Song YS, Kim JG, Lee HP, Kang SB. 2008. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 140(1):71-75.
18. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK. 2007. Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens 69(2):113-120. (Pubitemid 46174864)
19. Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, Yoon JH, Kim CY, Kim MS, Kim JY, Jung JH, Kim LH, Park BL, Shin HD. 2003. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35(3):196-202. (Pubitemid 36841640)
20. Kirmaz C, Terzioglu E, Topalak O, Bayrak P, Yilmaz O, Ersoz G, Sebik F. 2004. Serum transforming growth factor-beta1(TGFbeta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Eur Cytokine Netw 15(2):112-116. (Pubitemid 38980084)
21. Kumar V, Khosla R, Kumar A, Gupta V, Sarin BC. 2007. Transforming growth factor-beta 1 gene polymorphism in tuberculosis patients. Int J Hum Genet 7:249-252.
22. Lichtenstein M, Zimran A, Horowitz M. 1997. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 23(3):395-401. (Pubitemid 28123721)
23. Lin WW, Karin M. 2007. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117(5):1175-1183. (Pubitemid 46718402)
24. Liu L, Xu Y, Liu Z, Chen J, Zhang Y, Zhu J, Liu J, Liu S, Ji G, Shi H, Shen H, Hu Z. 2011. IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. Int J Cancer 128(7):1692-1696.
25. Manilal A, Rani C, Sabarathnam B, Seghal KG, Selvin J, Sugathan S, Shakir C. 2010. Iranica Journal of Energy and Environment 1(3):179-183.
26. Morahan G, Boutlis CS, Huang D, Pain A, Saunders JR, Hobbs MR, Granger DL, Weinberg JB, Peshu N, Mwaikambo ED, Marsh K, Roberts DJ, Anstey NM. 2002. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun 3(7):414-418. (Pubitemid 41656540)
27. Nieters A, Yuan JM, Sun CL, Zhang ZQ, Stoehlmacher J, Govindarajan S, Yu MC. 2005. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103(4):740-748. (Pubitemid 40216402)
28. Ognjanovic S, Yuan JM, Chaptman AK, Fan Y, Yu MC. 2009.Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 30(5):758-762.
29. Okumoto K, Hattori E, Tamura K, Kiso S, Watanabe H, Saito K, Saito T, Togashi H, Kawata S. 2004. Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma. Liver Int 24(1):21-28. (Pubitemid 38351210)
30. Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF. 2009.-509C T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection. Cancer Immunol Immunother 58(9):1433-1440.
31. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99(12):3025-3033. (Pubitemid 27278680)
32. Saxena R, Chawla YK, Verma I, Kaur JK. 2013. Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India. J Interferon Cytokine Res 33: 80-89.
33. Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Line SR. 2002. Investigation of an IL-2 polymorphism in patients with different levels of chronic periodontitis. J Clin Periodontol 29(7):587-591. (Pubitemid 41705004)
34. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G. 2002. A TaqI polymorphism in the 3¢UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 3(7): 419-423. (Pubitemid 41656541)
35. Song le H, Binh VQ, Duy DN, Kun JF, Bock TC, Kremsner PG, Luty AJ. 2003. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28(1):93-103. (Pubitemid 36970109)
36. Stanilova S, Miteva L. 2005. Taq-I polymorphism in 3¢UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun 6(4):364-366. (Pubitemid 40903410)
37. Suneetha PV, Goyal A, Hissar SS, Sarin SK. 2006. Studies on TAQ1 polymorphism in the 3¢untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3. J Med Virol 78(8):1055-1060.
38. Tamizifar B, Lankarani K, Naeimi S, Zadeh MR, Taghavi A, Ghaderi A. 2008. Promoter polymorphism of transforming growth factor-b1 gene and ulcerative colitis. World J Gastroenterol 14(2):243-247. (Pubitemid 351314306)
39. Trajkov D, Arsov T, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Spiroski M. 2005. Cytokine gene polymorphisms in population of ethnic Macedonians. Croat Med J 46(4):685-692. (Pubitemid 41248195)
40. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK. 2004. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 190(5):913-919. (Pubitemid 39120968)
41. Vidyarani M, Selvaraj P, Prabhu Anand S, Jawahar MS, Adhilakshmi AR, Narayanan PR. 2006. Interferon gamma (IFNgamma) and interleukin-4 (IL-4) gene variants and cytokine levels in pulmonary tuberculosis. Indian J Med Res 124(4): 403-410. (Pubitemid 46592121)
42. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. 2008. Genetic susceptibility of epidermal growth factor + 61A G and transforming growth factor beta1-509C T gene polymorphisms with gallbladder cancer. Hum Immunol 69(6): 360-367.
43. Wei YS, Xu QQ, Wang CF, Pan Y, Liang F, Long XK. 2007. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens 70(6):464-469. (Pubitemid 350075787)
44. Yamada Y. 2001. Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics 11(9):765-771. (Pubitemid 33151511)
45. Yilmaz V, Demirbilek V, Gurses C, Yentur SP, Uysal S, Yapici Z, Yilmaz G, Muncey A, Cokar O, Onal E, Gokyigit A, Saruhan-Direskeneli G. 2007. Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13(5):410-415. (Pubitemid 350104387)
46. Zafra G, Morillo C, Martin J, Gonzalez A, Gonzalez CI. 2007. Polymorphism in the 3¢ UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 9(9):1049-1052. (Pubitemid 47299211)
47. Zhou L, Liu J, Luo F. 2006. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 12(8): 1175-1181